Surgery is recommended for early-stage PPLELC, while the treatment strategy for advanced-stage PPLELC is referenced to that for NPC, including gemcitabine-based chemotherapy, taxanes, anti-angiogenic therapy, and anti-PD1/PD-L1 therapy [15]. The gene discussed is CD274; the disease is nasopharyngeal carcinoma.